Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in CSBR — Champions Oncology, Inc.

CIK 916542 Boston, MA
Back to CSBR Full portfolio

Position in CSBR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$126,421
+$3,814 QoQ
Shares Held
20,523
-3.8% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 28 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CSBR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. CSBR ranks #127 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in CSBR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $126,421 20,523
2026-03-31 $122,607 21,323
2025-12-31 $207,265 29,995
2025-09-30 $234,459 36,182
2025-06-30 $266,661 36,182
2025-03-31 $342,955 39,511
2024-12-31 $263,073 30,697
2024-09-30 $149,494 30,697
2024-06-30 $158,703 30,697
2024-03-31 $150,415 30,697
2023-12-31 $172,517 30,697
2023-09-30 $190,628 30,697
2023-06-30 $195,846 30,697
2023-03-31 $126,533 31,476
2022-12-31 $141,956 31,476
2022-09-30 $236,070 31,476
2022-06-30 $251,808 31,476
2022-03-31 $255,899 31,476
2021-12-31 $263,139 31,476
2021-09-30 $321,369 31,476
2021-06-30 $323,583 31,477
2021-03-31 $355,690 31,477
2020-12-31 $295,937 27,427
2020-09-30 $233,877 25,284
2020-06-30 $195,807 20,482
2020-03-31 $135,405 18,298